1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
North America Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Wound ; End User ; and Country

North America Biofilms Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Wound ; End User ; and Country

  • December 2020
  • 122 pages
  • ID: 6004201
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Mar 10th 2021


Table of Contents

Search Inside

The North America biofilms treatment market is expected to reach US$ 951.16 million by 2027 from US$ 546.93 million in 2019. The market is estimated to grow with a CAGR of 7.2% from 2020 to 2027.
The growth of North America biofilms treatment market is driven by the increasing prevalence of diabetic foot ulcer and growing cases of burn injuries across the region. However, the market is expected experience slow growth during the forecast period owing to the expensive healthcare across North America.
Diabetic Mellitus (DM) is recognized to have an epidemic prevalence in the US as compared to the incidence of the condition across the globe.With an increasing number of diabetic patients, complications associated with it are also rising.

Diabetic foot ulcers (DFU), one of the diabetic related complications, has an estimated lifetime incidence of 15% among diabetic patients.Biofilm is an aggregation of various bacterial species that are adhered on the surface of the wound.

Biofilms are also thought to be one of the reasons for the nonhealing of diabetic foot ulcers.Thus, biofilm treatment plays an essential role in wound healing.

The growing prevalence of diabetes increases the demand for biofilms treatment. According to the International Diabetes Federation study—global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045—the prevalence of diabetes in 2019 was around 9.3%, about 463 million people. It is expected to reach 10.2%, which is ~578 million by 2030. Furthermore, as per the study - Diabetic Foot: Facts And Figures 2017, the risk of a diabetic patient developing foot ulcer is 34% in their lifetime; more than 50% of the diabetic foot ulcers become infected, and 20% of the infected foot ulcers result in amputations. DFU (Diabetic Foot Ulcer) is known to increase the risk of infections, amputations, and even death in worst cases, hence requiring prompt treatment and surveillance of such ulcers. Various organizations and journals have published best practices to heal and close DFU. However, despite the suggested guidelines, only 50% of diabetic foot ulcers are recovered within a year. It is stated that the average annual expenditure of diabetic foot care is ~US$ 8,659 per patient. The overall medical cost for the management of diabetic foot disease in the US ranges from US$ 9 to US$13 billion. Hence, the increasing prevalence of DFU drives the North America biofilms treatment market.
The COVID-19 pandemic is adversely affecting patient care in hospitals and acute care facilities, and it is expected to get worse in coming months.As a result, any procedure or service deemed “nonessential” is being shut down immediately.

Many hospitals have already categorized wound care as a nonessential procedure. MiMedx Group, Inc.—one of the major players in the biofilm treatment market—in their recent report mentioned that the sale of their product has been hampered by the pandemic. The company’s sales force is spread across the US. In many areas, the company’s sales force was excluded from hospitals and the offices of other health care providers. Also, many patients stayed away from hospitals and other medical facilities, which has hindered the revenues of the late first quarter of 2020 and continued in April. However, by mid-May, access to hospitals and healthcare providers by sales force had been mostly restored, and the company began to see significant numbers of patients returning to hospitals and other healthcare providers, including for elective procedures. The company stated that future sales will depend on the patient’s willingness and ability to visit healthcare providers and hospitals for care, and the sales force’s access to the healthcare providers. Also, the intensity of the COVID-19 pandemic has been uneven across the region. Furthermore, due to the outbreak, various hospitals are engaged in treating the affected people. Various wound care centers are located in hospitals; hence, the majority of the patients are not able to receive wound care. Approximately 1 in 4 patient can receive wound care, and it is expected that there are nearly 6.7 million people across the US those are waiting for the treatment. The outbreak is restraining the North America biofilms treatment market by restricting the quality care.
Based on product, the North America biofilms treatment market is segmented into debridement equipment, gauzes and dressings, grafts and matrices, and others. The gauzes and dressings segment held the largest share of the market in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
The North America biofilms treatment market, based on wound, is segmented into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and others. The traumatic and surgical wounds segment held the largest market share in 2019; the same segment is anticipated to register the highest CAGR in the market during 2020-2027.
Based on end user, the North America biofilms treatment market is segmented into hospitals, home care settings, and others.In 2019, the hospitals segment held the largest share of the market.

The same segment is anticipated to register the highest CAGR in the market from 2020 to 2027.
A few of the primary and secondary sources referred to while preparing the report on the North America biofilms treatment market are the International Diabetes Federation study and Canadian Association of Wound Care.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Antimicrobial Wound Dressings Market - Global Outlook and Forecast 2021-2026

  • $ 3750
  • February 2021
  • 276 pages

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Antimicrobial Wound Dressing Market Report The global antimicrobial wound dressing market by revenue is expected ...

  • World
  • Wound Care
  • Antimicrobial Wound Dressing
  • Industry analysis
  • Diabetes Prevalence
  • Elderly Population


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on